Design, Synthesis, and Evaluation of Highly Potent FAK-Targeting PROTACs
Hongying Gao(Tsinghua University), Yu Rao(Soochow University), Yiqing Yang(Tsinghua University), Guang‐Biao Zhou(Chinese Academy of Medical Sciences & Peking Union Medical College), Yonghui Sun(Tsinghua University), Yue Wu(Tsinghua University)
Cited by 85
Related Papers
PROTACs: great opportunities for academia and industry
|Signal Transduction and Targeted Therapy|2019|627
PROTAC Technology: Opportunities and Challenges
|ACS Medicinal Chemistry Letters|2020|353
PROTAC-induced BTK degradation as a novel therapy for mutated BTK C481S induced ibrutinib-resistant B-cell malignancies
|Cell Research|2018|280
Chemistries of bifunctional PROTAC degraders
|Chemical Society Reviews|2022|270